Chimeric Therapeutics Limited (ASX:CHM)

Chimeric Therapeutics Statistics

Total Valuation

ASX:CHM has a market cap or net worth of AUD 9.76 million. The enterprise value is 4.01 million.

Market Cap	9.76M
Enterprise Value	4.01M

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:CHM has 3.25 billion shares outstanding. The number of shares has increased by 94.34% in one year.

Current Share Class	3.25B
Shares Outstanding	3.25B
Shares Change (YoY)	+94.34%
Shares Change (QoQ)	+69.04%
Owned by Insiders (%)	10.27%
Owned by Institutions (%)	1.21%
Float	2.90B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
PB Ratio	4.94
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.38
EV / Sales	0.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.71
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-64.43

Financial Efficiency

Return on equity (ROE) is -469.35% and return on invested capital (ROIC) is -382.37%.

Return on Equity (ROE)	-469.35%
Return on Assets (ROA)	-46.13%
Return on Invested Capital (ROIC)	-382.37%
Return on Capital Employed (ROCE)	-195.40%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.69
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:CHM has paid 110,809 in taxes.

Income Tax	110,809
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.25% in the last 52 weeks. The beta is 1.55, so ASX:CHM's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	-81.25%
50-Day Moving Average	0.00
200-Day Moving Average	0.01
Relative Strength Index (RSI)	48.11
Average Volume (20 Days)	9,139,055

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:CHM had revenue of AUD 12.68 million and -10.43 million in losses. Loss per share was -0.01.

Revenue	12.68M
Gross Profit	11.84M
Operating Income	-13.60M
Pretax Income	-10.32M
Net Income	-10.43M
EBITDA	-12.56M
EBIT	-13.60M
Loss Per Share	-0.01

Balance Sheet

The company has 5.76 million in cash and n/a in debt, giving a net cash position of 5.76 million or 0.00 per share.

Cash & Cash Equivalents	5.76M
Total Debt	n/a
Net Cash	5.76M
Net Cash Per Share	0.00
Equity (Book Value)	1.97M
Book Value Per Share	0.00
Working Capital	-4.09M

Cash Flow

Operating Cash Flow	-7.28M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 93.32%, with operating and profit margins of -107.18% and -82.23%.

Gross Margin	93.32%
Operating Margin	-107.18%
Pretax Margin	-81.36%
Profit Margin	-82.23%
EBITDA Margin	-99.05%
EBIT Margin	-107.18%
FCF Margin	n/a

Dividends & Yields

ASX:CHM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-94.34%
Shareholder Yield	n/a
Earnings Yield	-106.83%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:CHM has an Altman Z-Score of -6.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.34
Piotroski F-Score	3